See the Aventi 340B Rebate Model Demo.
340B TPA FAQ

Who is responsible for 340B compliance: the TPA or the covered entity?

Short answer

The covered entity. A 340B TPA can run eligibility logic, accumulators, replenishment orders, Medicaid filters and reporting for you, but it can’t take on the legal duty. The 340B statute puts the bans on diversion and duplicate discounts on the covered entity, makes the covered entity’s records subject to HRSA and manufacturer audits, and makes the covered entity liable to manufacturers when violations are found. HRSA’s contract pharmacy guidance says the same thing in plain words: the covered entity “retain[s] ultimate responsibility for compliance with the 340B program.” What you can do is choose a TPA whose work you can see, check and correct, and put that in the contract.[1][2]

Accountable party
The covered entity

The TPA runs the work. You own the result.

In HRSA’s words

The guidance repeats it more than once

“The covered entity has, and continues to bear, full responsibility and accountability for compliance with all requirements to prevent diversion … and to prevent situations in which a drug is subject to both the 340B discount and a Medicaid Rebate claim.”
HRSA contract pharmacy guidance, 2010[1]
“The covered entity remains responsible at all times for the disposition of covered outpatient drugs it purchases through a contract pharmacy.”
HRSA contract pharmacy guidance, 2010[1]
“The covered entity bears responsibility for compliance with the program and will be held accountable in the event of non-compliance.”
HRSA contract pharmacy guidance, 2010[1]

The same notice also says HRSA leaves it up to covered entities to decide how to meet these responsibilities. That flexibility is why the choice of TPA, and the terms you sign with it, matter so much.[1]

What the statute says

Every 340B duty names the covered entity

The 340B statute never mentions a TPA. These are the provisions that matter most for day-to-day compliance.

  1. § 256b(a)(5)(A)
    No duplicate discounts

    A covered entity shall not request Medicaid payment for a 340B drug that is also subject to a Medicaid rebate.[2]

  2. § 256b(a)(5)(B)
    No diversion

    A covered entity shall not resell or otherwise transfer a 340B drug to a person who is not its patient.[2]

  3. § 256b(a)(5)(C)
    Open records

    A covered entity shall let HRSA and manufacturers audit the entity’s records that pertain to those two requirements.[2]

  4. § 256b(a)(5)(D)
    Repayment

    If HRSA finds a violation after audit, notice and hearing, the covered entity is liable to the manufacturer for the discount it received.[2]

  5. § 256b(d)(2)(B)(v)
    Removal

    Diversion that is systematic and egregious as well as knowing and intentional can get a covered entity removed from the program and barred from re-entry for a period.[2]

Who does what

Covered entity, TPA and contract pharmacy, task by task

“Owns” means accountable to HRSA. “Runs” means does the day-to-day work under your rules. “Supports” means provides data or help. Your contracts may divide the work differently, but the Owns column doesn’t move.

TaskCovered entityTPAContract pharmacyWhy
Registering sites and contract pharmacies in OPAIS; annual recertificationOwnsSupports—An authorized official of the covered entity certifies, including that contract pharmacy arrangements were performed as required.[1][3]
Written contract pharmacy agreement covering the essential elementsOwns—SupportsHRSA lists the elements (a)–(j) the agreement should address; the TPA is usually a separate contract.[1]
Patient eligibility rules (who counts as your patient)OwnsRunsSupportsElement (h): the covered entity and pharmacy develop a system to verify eligibility. A TPA typically applies the rules you set to each claim.[1]
Tracking system and prescribing-vs-dispensing comparisonsOwnsRunsSupportsElement (g): a tracking system suitable to prevent diversion, plus periodic comparison of your prescribing records with dispensing records.[1]
Medicaid carve-in / carve-out decision and duplicate discount preventionOwnsRunsSupportsElement (i): no 340B drug for Medicaid prescriptions at a contract pharmacy unless an arrangement with the state is in place and reported to HRSA.[1][2]
Purchasing, title and price of 340B drugs (ship-to, bill-to)OwnsSupportsSupportsElement (a): the covered entity purchases the drug, keeps title and sets its price.[1]
Reports and auditable recordsOwnsRunsSupportsThe covered entity must have sufficient records, or direct access to records, to provide a complete audit trail.[1][2]
Internal and independent audits of contract pharmaciesOwnsSupportsSupportsHRSA expects annual independent audits; its FAQ also points to quarterly internal reviews.[1][4]
Self-disclosure, corrective action and manufacturer repaymentOwnsSupports—The covered entity notifies HRSA, fixes the problem, and contacts affected manufacturers about repayment.[1][3]
Delegation

What you can hand off, and what stays with you

A TPA can do the work

  • +Running claims through your eligibility rules every day
  • +Keeping accumulators and placing replenishment orders
  • +Applying Medicaid Exclusion File and carve-out settings to claims
  • +Producing claim-level, financial and audit-ready reports
  • +Flagging exceptions and errors for your team to review
  • +Pulling the data an auditor asks for, fast

The accountability stays with you

  • •The legal duty to prevent diversion and duplicate discounts
  • •Defining who is a patient of your entity, and your policies and procedures
  • •Signing annual recertification and keeping OPAIS accurate
  • •Deciding to self-disclose and approving the corrective action plan
  • •Repaying manufacturers when a violation is found
  • •Overseeing the TPA and every contract pharmacy

GAO recommended in 2018 that HRSA give more specific guidance on the scope and frequency of contract pharmacy oversight; GAO still lists that recommendation as open.[5]

When a TPA error becomes a finding

What happens, and who handles each step

  1. 1

    You (or your TPA) find a problem

    HRSA’s guidance says to take immediate remedial action and notify HRSA of the problem and the fix. HRSA runs a self-disclosure process for exactly this.[1][3][4]

  2. 2

    An auditor finds it first

    HRSA’s audits are of covered entities and manufacturers, not TPAs. Its procedures test internal controls and compliance at the entity, its sites and its contract pharmacies, using your transaction records.[3]

  3. 3

    Final report and CAP

    You have 30 calendar days to respond to a final report. If you agree, a corrective action plan is due within 60 days; failing to submit one can lead to removal.[3]

  4. 4

    Repayment

    HRSA expects the CAP and manufacturer settlements done within six months of CAP approval. The covered entity identifies and contacts every affected manufacturer.[2][3]

  5. 5

    Repeat findings

    The same finding on re-audit can mean more audits. Diversion found in two or more audits may be treated as systematic and egregious, and knowing and intentional.[2][3]

For the full audit process, see how to prepare for a HRSA 340B audit with your TPA.

Your TPA agreement

Six terms that let you carry the responsibility

You can’t contract the duty away, but you can make sure you have what you need to meet it.

01

Direct access to your data

Claim-level detail and history you can pull yourself, so you always have the audit trail HRSA expects you to hold.[1]

02

Your rules, documented

Every eligibility setting traced back to your policies, with a log of who changed what and when.[1]

03

Audit cooperation

A commitment to produce data and explain the logic for a HRSA or manufacturer audit within the audit’s timelines.[3]

04

Error correction

How the TPA tells you about a mistake, how fast it fixes it, and how it helps you size the impact for a self-disclosure or repayment.[3]

05

HIPAA business associate agreement

A TPA that handles patient claims data on your behalf is generally a HIPAA business associate, so a BAA should be in place.[6]

06

Records after you leave

A clean export of historical claims if you switch, so past years stay auditable.[1]

Comparing vendors? Use our 340B TPA comparison and see what reporting a 340B TPA should provide.

How Aventi helps

A TPA built so you can see and prove your compliance

Audit-ready claims

Claim-level detail, duplicate discount monitoring and Good Faith Inquiry tracking, so the records HRSA expects you to hold are ready when an auditor asks.

A team that answers to you

A dedicated account manager and portal access for your team. We run contract pharmacy and split billing for 300 covered entities, 24 of them hospitals.

No end-of-month true-ups

Real-time claim capture and purchase splitting mean fewer surprises in the numbers you sign off on. See how accumulators and split billing work.

Ready for 2027 rebates

The rebate module is Included for Aventi TPA clients, with real-time 340B ESP and Truzo (Kalderos) integration. Learn about the 2027 340B rebate model.

FAQ

340B compliance responsibility: common questions

Not under the 340B program. The statute’s bans on diversion and duplicate discounts, the audit right and the repayment liability all name the covered entity, and HRSA’s guidance says the covered entity keeps ultimate responsibility. Any recourse you have against a TPA for its errors comes from your contract with it.[1][2]

HRSA’s published audit program covers covered entities and manufacturers. A covered entity audit reviews compliance at the entity, its sites and its contract pharmacies and tests your 340B transaction records, much of which your TPA produces. So the TPA’s data is examined, but the findings are written against the covered entity.[3]

Yes. When HRSA finds a violation, the covered entity is liable to the manufacturer for the discount, and HRSA expects the covered entity to identify and contact every affected manufacturer. Whether the TPA shares the cost depends on your agreement.[2][3]

An authorized official of the covered entity. HRSA’s 2010 guidance describes certifying that the OPAIS record is accurate, that eligibility was met, that contract pharmacy arrangements were performed as required (including getting enough information from the contractor), and the method used to ensure compliance.[1][3]

HRSA expects covered entities to oversee their arrangements, with annual independent audits as the expected approach and quarterly internal reviews in its FAQ. A good TPA makes those reviews faster, but it doesn’t replace them. GAO has noted that HRSA’s guidance on the scope and frequency of this oversight is still not specific.[1][4][5]

The pharmacy agrees to follow federal, state and local law, and both parties are aware of potential penalties if either breaks it. But for 340B program purposes HRSA says the covered entity remains responsible at all times for drugs it buys through a contract pharmacy.[1]

Size it, fix it and decide on disclosure. HRSA’s guidance says to take immediate remedial action and tell HRSA about the problem and the fix, and HRSA runs a self-disclosure process for this. Ask the TPA for claim-level detail so you can see which manufacturers and periods are affected.[1][3][4]

Generally, yes, if it handles patient claims data on your behalf. HHS describes business associates as organizations that perform functions such as claims processing or administration, data analysis or billing involving PHI for a covered entity, which requires a business associate agreement.[6]

Sources

  1. Federal Register, Notice Regarding 340B Drug Pricing Program—Contract Pharmacy Services, 75 FR 10272 (Mar. 5, 2010), comment responses, essential elements (a)–(j), ongoing responsibility and certification sections — https://www.federalregister.gov/documents/2010/03/05/2010-4755/notice-regarding-340b-drug-pricing-program-contract-pharmacy-services
  2. 42 U.S.C. § 256b(a)(5)(A)–(D) (duplicate discounts, diversion, auditing, liability to manufacturers) and (d)(2)(B)(v) (sanctions) (Cornell LII) — https://www.law.cornell.edu/uscode/text/42/256b
  3. HRSA Office of Pharmacy Affairs, Program Integrity (audit scope and procedures, final report, CAP, repayment, re-audits, recertification, self-disclosure) — https://www.hrsa.gov/opa/program-integrity
  4. HRSA FAQ, What are the audit and compliance parameters under the contract pharmacy guidelines? — https://www.hrsa.gov/about/faqs/what-are-audit-compliance-parameters-under-contract-pharmacy-guidelines
  5. U.S. GAO, Drug Discount Program: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement, GAO-18-480 (June 2018), Recommendation 7 status — https://www.gao.gov/products/gao-18-480
  6. HHS Office for Civil Rights, Business Associates Frequently Asked Questions (HIPAA) — https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/business-associates/index.html

Last updated November 18, 2026. This page is general information, not legal advice. Check HRSA’s current guidance and your own counsel for your program.